Selected research
Industry Research
Artemisinin and Derivatives Industry Research Report 2026
Market perspective
The global Artemisinin and Derivatives market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Artemisinin and Derivatives is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Artemisinin and Derivatives is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Artemisinin and Derivatives is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Artemisinin and Derivatives include among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Artemisinin and Derivatives market in revenue (US$ million) and, where applicable, sales volume (Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Artemisinin and Derivatives.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Artemisinin and Derivatives Market by Company
Ipca Laboratories
Guilin Nantang Pharmaceutical
KPC Pharmaceuticals
Chongqing Kerui Nanhai Pharmaceutical
Sichuan Xieli Pharmaceutical
Cerata Pharmaceuticals
Aqre Group
Artemisinin and Derivatives Segment by Type
Artemether
Artesunate
Artemisinin
Dihydroartemisinin
Artemisinin and Derivatives Segment by Application
Antitumor and Anti-inflammatory Drugs
Antimalarial Drugs
Artemisinin and Derivatives Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artemisinin and Derivatives market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Artemisinin and Derivatives and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artemisinin and Derivatives.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Artemisinin and Derivatives manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Artemisinin and Derivatives by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Artemisinin and Derivatives in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Artemether
- Artesunate
- Artemisinin
- Dihydroartemisinin
Applications
- Antitumor and Anti-inflammatory Drugs
- Antimalarial Drugs
Companies covered
- Ipca Laboratories
- Guilin Nantang Pharmaceutical
- KPC Pharmaceuticals
- Chongqing Kerui Nanhai Pharmaceutical
- Sichuan Xieli Pharmaceutical
- Cerata Pharmaceuticals
- Aqre Group
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Artemisinin and Derivatives by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 Artemether
- 2.2.3 Artesunate
- 2.2.4 Artemisinin
- 2.2.5 Dihydroartemisinin
- 2.3 Artemisinin and Derivatives by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Antitumor and Anti-inflammatory Drugs
- 2.3.3 Antimalarial Drugs
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Artemisinin and Derivatives Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global Artemisinin and Derivatives Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global Artemisinin and Derivatives Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global Artemisinin and Derivatives Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Artemisinin and Derivatives Production by Manufacturers (2021-2026)
- 3.2 Global Artemisinin and Derivatives Production Value by Manufacturers (2021-2026)
- 3.3 Global Artemisinin and Derivatives Average Price by Manufacturers (2021-2026)
- 3.4 Global Artemisinin and Derivatives Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Artemisinin and Derivatives Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Artemisinin and Derivatives Manufacturers, Product Type & Application
- 3.7 Global Artemisinin and Derivatives Manufacturers Established Date
- 3.8 Global Artemisinin and Derivatives Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Ipca Laboratories
- 4.1.1 Ipca Laboratories Artemisinin and Derivatives Company Information
- 4.1.2 Ipca Laboratories Artemisinin and Derivatives Business Overview
- 4.1.3 Ipca Laboratories Artemisinin and Derivatives Production Capacity, Value and Gross Margin (2021-2026)
- 4.1.4 Ipca Laboratories Product Portfolio
- 4.1.5 Ipca Laboratories Recent Developments
- 4.2 Guilin Nantang Pharmaceutical
- 4.2.1 Guilin Nantang Pharmaceutical Artemisinin and Derivatives Company Information
- 4.2.2 Guilin Nantang Pharmaceutical Artemisinin and Derivatives Business Overview
- 4.2.3 Guilin Nantang Pharmaceutical Artemisinin and Derivatives Production Capacity, Value and Gross Margin (2021-2026)
- 4.2.4 Guilin Nantang Pharmaceutical Product Portfolio
- 4.2.5 Guilin Nantang Pharmaceutical Recent Developments
- 4.3 KPC Pharmaceuticals
- 4.3.1 KPC Pharmaceuticals Artemisinin and Derivatives Company Information
- 4.3.2 KPC Pharmaceuticals Artemisinin and Derivatives Business Overview
- 4.3.3 KPC Pharmaceuticals Artemisinin and Derivatives Production Capacity, Value and Gross Margin (2021-2026)
- 4.3.4 KPC Pharmaceuticals Product Portfolio
- 4.3.5 KPC Pharmaceuticals Recent Developments
- 4.4 Chongqing Kerui Nanhai Pharmaceutical
- 4.4.1 Chongqing Kerui Nanhai Pharmaceutical Artemisinin and Derivatives Company Information
- 4.4.2 Chongqing Kerui Nanhai Pharmaceutical Artemisinin and Derivatives Business Overview
- 4.4.3 Chongqing Kerui Nanhai Pharmaceutical Artemisinin and Derivatives Production Capacity, Value and Gross Margin (2021-2026)
- 4.4.4 Chongqing Kerui Nanhai Pharmaceutical Product Portfolio
- 4.4.5 Chongqing Kerui Nanhai Pharmaceutical Recent Developments
- 4.5 Sichuan Xieli Pharmaceutical
- 4.5.1 Sichuan Xieli Pharmaceutical Artemisinin and Derivatives Company Information
- 4.5.2 Sichuan Xieli Pharmaceutical Artemisinin and Derivatives Business Overview
- 4.5.3 Sichuan Xieli Pharmaceutical Artemisinin and Derivatives Production Capacity, Value and Gross Margin (2021-2026)
- 4.5.4 Sichuan Xieli Pharmaceutical Product Portfolio
- 4.5.5 Sichuan Xieli Pharmaceutical Recent Developments
- 4.6 Cerata Pharmaceuticals
- 4.6.1 Cerata Pharmaceuticals Artemisinin and Derivatives Company Information
- 4.6.2 Cerata Pharmaceuticals Artemisinin and Derivatives Business Overview
- 4.6.3 Cerata Pharmaceuticals Artemisinin and Derivatives Production Capacity, Value and Gross Margin (2021-2026)
- 4.6.4 Cerata Pharmaceuticals Product Portfolio
- 4.6.5 Cerata Pharmaceuticals Recent Developments
- 4.7 Aqre Group
- 4.7.1 Aqre Group Artemisinin and Derivatives Company Information
- 4.7.2 Aqre Group Artemisinin and Derivatives Business Overview
- 4.7.3 Aqre Group Artemisinin and Derivatives Production Capacity, Value and Gross Margin (2021-2026)
- 4.7.4 Aqre Group Product Portfolio
- 4.7.5 Aqre Group Recent Developments
5 Global Artemisinin and Derivatives Production by Region
- 5.1 Global Artemisinin and Derivatives Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global Artemisinin and Derivatives Production by Region: 2021-2032
- 5.2.1 Global Artemisinin and Derivatives Production by Region: 2021-2026
- 5.2.2 Global Artemisinin and Derivatives Production Forecast by Region (2027-2032)
- 5.3 Global Artemisinin and Derivatives Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global Artemisinin and Derivatives Production Value by Region: 2021-2032
- 5.4.1 Global Artemisinin and Derivatives Production Value by Region: 2021-2026
- 5.4.2 Global Artemisinin and Derivatives Production Value Forecast by Region (2027-2032)
- 5.5 Global Artemisinin and Derivatives Market Price Analysis by Region (2021-2026)
- 5.6 Global Artemisinin and Derivatives Production and Value, YOY Growth
- 5.6.1 North America Artemisinin and Derivatives Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe Artemisinin and Derivatives Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China Artemisinin and Derivatives Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan Artemisinin and Derivatives Production Value Estimates and Forecasts (2021-2032)
6 Global Artemisinin and Derivatives Consumption by Region
- 6.1 Global Artemisinin and Derivatives Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global Artemisinin and Derivatives Consumption by Region (2021-2032)
- 6.2.1 Global Artemisinin and Derivatives Consumption by Region: 2021-2026
- 6.2.2 Global Artemisinin and Derivatives Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Artemisinin and Derivatives Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Artemisinin and Derivatives Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Artemisinin and Derivatives Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Artemisinin and Derivatives Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Artemisinin and Derivatives Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Artemisinin and Derivatives Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Artemisinin and Derivatives Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa Artemisinin and Derivatives Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global Artemisinin and Derivatives Production by Type (2021-2032)
- 7.1.1 Global Artemisinin and Derivatives Production by Type (2021-2032) & (Tons)
- 7.1.2 Global Artemisinin and Derivatives Production Market Share by Type (2021-2032)
- 7.2 Global Artemisinin and Derivatives Production Value by Type (2021-2032)
- 7.2.1 Global Artemisinin and Derivatives Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global Artemisinin and Derivatives Production Value Market Share by Type (2021-2032)
- 7.3 Global Artemisinin and Derivatives Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global Artemisinin and Derivatives Production by Application (2021-2032)
- 8.1.1 Global Artemisinin and Derivatives Production by Application (2021-2032) & (Tons)
- 8.1.2 Global Artemisinin and Derivatives Production Market Share by Application (2021-2032)
- 8.2 Global Artemisinin and Derivatives Production Value by Application (2021-2032)
- 8.2.1 Global Artemisinin and Derivatives Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global Artemisinin and Derivatives Production Value Market Share by Application (2021-2032)
- 8.3 Global Artemisinin and Derivatives Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Artemisinin and Derivatives Value Chain Analysis
- 9.1.1 Artemisinin and Derivatives Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Artemisinin and Derivatives Production Mode & Process
- 9.2 Artemisinin and Derivatives Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Artemisinin and Derivatives Distributors
- 9.2.3 Artemisinin and Derivatives Customers
10 Global Artemisinin and Derivatives Analyzing Market Dynamics
- 10.1 Artemisinin and Derivatives Industry Trends
- 10.2 Artemisinin and Derivatives Industry Drivers
- 10.3 Artemisinin and Derivatives Industry Opportunities and Challenges
- 10.4 Artemisinin and Derivatives Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst